{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:04:10Z","timestamp":1787753050880,"version":"build-2784847793"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T00:00:00Z","timestamp":1593993600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001116","name":"Foundation Fighting Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001116","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003212","name":"Sara Elizabeth O'Brien Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003212","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002089","name":"Fight for Sight","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002089","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.omtm.2020.07.003","type":"journal-article","created":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T21:25:28Z","timestamp":1594243528000},"page":"582-594","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Gene Therapy Preserves Retinal Structure and Function in a Mouse Model of NMNAT1-Associated Retinal Degeneration"],"prefix":"10.1016","volume":"18","author":[{"given":"Scott H.","family":"Greenwald","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily E.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Scandura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Hennessey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Farmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basil S.","family":"Pawlyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luk H.","family":"Vandenberghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A.","family":"Pierce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2020.07.003_bib1","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1038\/ng.2370","article-title":"Exome sequencing identifies NMNAT1 mutations as a cause of Leber congenital amaurosis","volume":"44","author":"Chiang","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtm.2020.07.003_bib2","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/ng.2356","article-title":"Mutations in NMNAT1 cause Leber congenital amaurosis and identify a new disease pathway for retinal degeneration","volume":"44","author":"Koenekoop","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtm.2020.07.003_bib3","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/ng.2357","article-title":"Mutations in NMNAT1 cause Leber congenital amaurosis with early-onset severe macular and optic atrophy","volume":"44","author":"Perrault","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtm.2020.07.003_bib4","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1038\/ng.2361","article-title":"NMNAT1 mutations cause Leber congenital amaurosis","volume":"44","author":"Falk","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtm.2020.07.003_bib5","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/s41431-017-0029-7","article-title":"NMNAT1 variants cause cone and cone-rod dystrophy","volume":"26","author":"Nash","year":"2018","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.omtm.2020.07.003_bib6","doi-asserted-by":"crossref","first-page":"8524","DOI":"10.1074\/jbc.M111589200","article-title":"Structure of human NMN adenylyltransferase. A key nuclear enzyme for NAD homeostasis","volume":"277","author":"Garavaglia","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtm.2020.07.003_bib7","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.tibs.2006.11.006","article-title":"NAD+ metabolism in health and disease","volume":"32","author":"Belenky","year":"2007","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.omtm.2020.07.003_bib8","doi-asserted-by":"crossref","first-page":"410","DOI":"10.2741\/3252","article-title":"The NMN\/NaMN adenylyltransferase (NMNAT) protein family","volume":"14","author":"Lau","year":"2009","journal-title":"Front. Biosci."},{"key":"10.1016\/j.omtm.2020.07.003_bib9","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nrc3340","article-title":"The NAD metabolome\u2014a key determinant of cancer cell biology","volume":"12","author":"Chiarugi","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.omtm.2020.07.003_bib10","doi-asserted-by":"crossref","first-page":"17228","DOI":"10.1074\/jbc.M115.637850","article-title":"Characterization of Leber\u2019s congenital amaurosis-associated NMNAT1 mutants","volume":"290","author":"Sasaki","year":"2015","journal-title":"J.\u00a0Biol. Chem"},{"key":"10.1016\/j.omtm.2020.07.003_bib11","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1002\/humu.22899","article-title":"Hidden genetic variation in LCA9-associated congenital blindness explained by 5'UTR mutations and copy-number variations of NMNAT1","volume":"36","author":"Coppieters","year":"2015","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.omtm.2020.07.003_bib12","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1111\/j.1742-4658.2011.08193.x","article-title":"Reducing expression of NAD+ synthesizing enzyme NMNAT1 does not affect the rate of Wallerian degeneration","volume":"278","author":"Conforti","year":"2011","journal-title":"FEBS J."},{"key":"10.1016\/j.omtm.2020.07.003_bib13","doi-asserted-by":"crossref","first-page":"36334","DOI":"10.1074\/jbc.M508660200","article-title":"Subcellular compartmentation and differential catalytic properties of the three human nicotinamide mononucleotide adenylyltransferase isoforms","volume":"280","author":"Berger","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtm.2020.07.003_bib14","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.ajpath.2016.03.013","article-title":"Mouse models of NMNAT1-Leber congenital amaurosis (LCA9) recapitulate key features of the human disease","volume":"186","author":"Greenwald","year":"2016","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.omtm.2020.07.003_bib15","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/978-3-030-27378-1_53","article-title":"Parthanatos as a cell death pathway underlying retinal disease","volume":"1185","author":"Greenwald","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.omtm.2020.07.003_bib16","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.visres.2014.07.013","article-title":"Promising and delivering gene therapies for vision loss","volume":"111","author":"Carvalho","year":"2015","journal-title":"Vision Res."},{"key":"10.1016\/j.omtm.2020.07.003_bib17","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s11095-018-2564-5","article-title":"Adeno-associated viral gene therapy for inherited retinal disease","volume":"36","author":"Ong","year":"2019","journal-title":"Pharm. Res."},{"key":"10.1016\/j.omtm.2020.07.003_bib18","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1038\/mt.2008.171","article-title":"Self-complementary AAV vectors; advances and applications","volume":"16","author":"McCarty","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2020.07.003_bib19","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1136\/bjophthalmol-2018-313089","article-title":"Estimation of impact of RPE65-mediated inherited retinal disease on quality of life and the potential benefits of gene therapy","volume":"103","author":"Lloyd","year":"2019","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.omtm.2020.07.003_bib20","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ajo.2018.09.012","article-title":"Choroideremia gene therapy phase 2 clinical trial: 24-month results","volume":"197","author":"Lam","year":"2019","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.omtm.2020.07.003_bib21","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00439-016-1637-y","article-title":"Treatment of retinitis pigmentosa due to MERTK mutations by ocular subretinal injection of adeno-associated virus gene vector: results of a phase I trial","volume":"135","author":"Ghazi","year":"2016","journal-title":"Hum. Genet."},{"key":"10.1016\/j.omtm.2020.07.003_bib22","unstructured":"ClinicalTrials.gov. Achromatopsia. https:\/\/clinicaltrials.gov\/ct2\/results?cond=Achromatopsia&term=&cntry=&state=&city=&dist=."},{"key":"10.1016\/j.omtm.2020.07.003_bib23","unstructured":"ClinicalTrials.gov. X-linked retinoschisis. https:\/\/clinicaltrials.gov\/ct2\/results?cond=X-linked+retinoschisis&term=&cntry=&state=&city=&dist=."},{"key":"10.1016\/j.omtm.2020.07.003_bib24","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1089\/hum.2019.132","article-title":"Dual ABCA4-AAV vector treatment reduces pathogenic retinal A2E accumulation in a mouse model of autosomal recessive Stargardt disease","volume":"30","author":"Dyka","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2020.07.003_bib25","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1089\/hum.2018.193","article-title":"Somatic gene editing of GUCY2D by AAV-CRISPR\/Cas9 alters retinal structure and function in mouse and macaque","volume":"30","author":"McCullough","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2020.07.003_bib26","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/978-1-4939-7522-8_10","article-title":"AAV gene augmentation therapy for CRB1-associated retinitis pigmentosa","volume":"1715","author":"Alves","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.omtm.2020.07.003_bib27","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1089\/hum.2018.076","article-title":"Six years and counting: restoration of photopic retinal function and visual behavior following gene augmentation therapy in a sheep model of CNGA3 achromatopsia","volume":"29","author":"Ofri","year":"2018","journal-title":"Hum. Gene Ther"},{"key":"10.1016\/j.omtm.2020.07.003_bib28","doi-asserted-by":"crossref","DOI":"10.1146\/annurev-genom-102319-103602","article-title":"Twenty-five years of spinal muscular atrophy research: from phenotype to genotype to therapy, and what comes next","author":"Wirth","year":"2020","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"10.1016\/j.omtm.2020.07.003_bib29","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.pep.2008.01.008","article-title":"Codon optimization can improve expression of human genes in Escherichia coli: a multi-gene study","volume":"59","author":"Burgess-Brown","year":"2008","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.omtm.2020.07.003_bib30","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.tibtech.2004.04.006","article-title":"Codon bias and heterologous protein expression","volume":"22","author":"Gustafsson","year":"2004","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.omtm.2020.07.003_bib31","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/sj.gt.3302524","article-title":"Gene therapy progress and prospects: recent progress in transgene and RNAi expression cassettes","volume":"12","author":"Ill","year":"2005","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2020.07.003_bib32","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1038\/mt.2008.186","article-title":"Codon and mRNA sequence optimization of microdystrophin transgenes improves expression and physiological outcome in dystrophic mdx mice following AAV2\/8 gene transfer","volume":"16","author":"Foster","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2020.07.003_bib33","doi-asserted-by":"crossref","first-page":"e37671","DOI":"10.1371\/journal.pone.0037671","article-title":"Transient B cell depletion or improved transgene expression by codon optimization promote tolerance to factor VIII in gene therapy","volume":"7","author":"Sack","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtm.2020.07.003_bib34","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/sj.gt.3301514","article-title":"Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis","volume":"8","author":"McCarty","year":"2001","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2020.07.003_bib35","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.omtn.2016.12.006","article-title":"Inclusion of the woodchuck hepatitis virus posttranscriptional regulatory element enhances AAV2-driven transduction of mouse and human retina","volume":"6","author":"Patr\u00edcio","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtm.2020.07.003_bib36","doi-asserted-by":"crossref","first-page":"e18556","DOI":"10.1371\/journal.pone.0018556","article-title":"High cleavage efficiency of a 2A peptide derived from porcine teschovirus-1 in human cell lines, zebrafish and mice","volume":"6","author":"Kim","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtm.2020.07.003_bib37","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.celrep.2015.07.019","article-title":"In silico reconstruction of the viral evolutionary lineage yields a potent gene therapy vector","volume":"12","author":"Zinn","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.omtm.2020.07.003_bib38","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1089\/hum.2017.154","article-title":"Synthetic adeno-associated viral vector efficiently targets mouse and nonhuman primate retina in\u00a0vivo","volume":"29","author":"Carvalho","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2020.07.003_bib39","doi-asserted-by":"crossref","first-page":"189ra76","DOI":"10.1126\/scitranslmed.3005708","article-title":"In\u00a0vivo-directed evolution of a new adeno-associated virus for therapeutic outer retinal gene delivery from the vitreous","volume":"5","author":"Dalkara","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtm.2020.07.003_bib40","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ajo.2015.10.009","article-title":"Evaluation of objective vitritis grading method using optical coherence tomography: influence of phakic status and previous vitrectomy","volume":"161","author":"Zarranz-Ventura","year":"2016","journal-title":"Am. J. Ophthalmol"},{"key":"10.1016\/j.omtm.2020.07.003_bib41","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/IAE.0b013e31826710ea","article-title":"Intravitreal cellular infiltrate imaged as punctate spots by spectral-domain optical coherence tomography in eyes with posterior segment inflammatory disease","volume":"33","author":"Saito","year":"2013","journal-title":"Retina"},{"key":"10.1016\/j.omtm.2020.07.003_bib42","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1085\/jgp.93.1.101","article-title":"B-wave of the electroretinogram. A reflection of ON bipolar cell activity","volume":"93","author":"Stockton","year":"1989","journal-title":"J.\u00a0Gen. Physiol."},{"key":"10.1016\/j.omtm.2020.07.003_bib43","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1364\/JOSAA.13.000557","article-title":"Inner retinal contributions to the primate photopic fast flicker electroretinogram","volume":"13","author":"Bush","year":"1996","journal-title":"J.\u00a0Opt. Soc. Am. A Opt. Image Sci. Vis."},{"key":"10.1016\/j.omtm.2020.07.003_bib44","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1017\/S0952523813000515","article-title":"S-opsin knockout mice with the endogenous M-opsin gene replaced by an L-opsin variant","volume":"31","author":"Greenwald","year":"2014","journal-title":"Vis. Neurosci."},{"key":"10.1016\/j.omtm.2020.07.003_bib45","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1113\/jphysiol.2002.030304","article-title":"Rod and cone contributions to the a-wave of the electroretinogram of the macaque","volume":"547","author":"Robson","year":"2003","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.omtm.2020.07.003_bib46","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.2741\/3409","article-title":"Vision tests in the mouse: functional phenotyping with electroretinography","volume":"14","author":"Tanimoto","year":"2009","journal-title":"Front. Biosci."},{"key":"10.1016\/j.omtm.2020.07.003_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cpmo.39","article-title":"Noninvasive electroretinographic procedures for the study of the mouse retina","volume":"8","author":"Kinoshita","year":"2018","journal-title":"Curr. Protoc. Mouse Biol."},{"key":"10.1016\/j.omtm.2020.07.003_bib48","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1113\/jphysiol.2002.019703","article-title":"The scotopic threshold response of the dark-adapted electroretinogram of the mouse","volume":"543","author":"Saszik","year":"2002","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.omtm.2020.07.003_bib49","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0304-3940(93)90547-X","article-title":"Properties of the mouse cone-mediated electroretinogram during light adaptation","volume":"162","author":"Peachey","year":"1993","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.omtm.2020.07.003_bib50","doi-asserted-by":"crossref","first-page":"e29892","DOI":"10.1371\/journal.pone.0029892","article-title":"Amyloid precursor protein is required for normal function of the rod and cone pathways in the mouse retina","volume":"7","author":"Ho","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtm.2020.07.003_bib51","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1017\/S0952523803202108","article-title":"Structure-function analysis of rods and cones in juvenile, adult, and aged C57BL\/6 and Balb\/c mice","volume":"20","author":"Gresh","year":"2003","journal-title":"Vis. Neurosci."},{"key":"10.1016\/j.omtm.2020.07.003_bib52","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/cne.901880205","article-title":"Rods and cones in the mouse retina. II. Autoradiographic analysis of cell generation using tritiated thymidine","volume":"188","author":"Carter-Dawson","year":"1979","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.omtm.2020.07.003_bib53","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1089\/hum.2017.020","article-title":"Rod outer segment development influences AAV-mediated photoreceptor transduction after subretinal injection","volume":"28","author":"Petit","year":"2017","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2020.07.003_bib54","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1128\/jvi.10.6.1118-1125.1972","article-title":"Adenovirus-associated virus multiplication. IX. Extent of transcription of the viral genome in\u00a0vivo","volume":"10","author":"Carter","year":"1972","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2020.07.003_bib55","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/sj.gt.3302987","article-title":"Differential internalization and nuclear uncoating of self-complementary adeno-associated virus pseudotype vectors as determinants of cardiac cell transduction","volume":"14","author":"Sipo","year":"2007","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2020.07.003_bib56","doi-asserted-by":"crossref","first-page":"13104","DOI":"10.1073\/pnas.0702778104","article-title":"Existence of transient functional double-stranded DNA intermediates during recombinant AAV transduction","volume":"104","author":"Wang","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2020.07.003_bib57","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1172\/JCI79735","article-title":"NRF2 promotes neuronal survival in neurodegeneration and acute nerve damage","volume":"125","author":"Xiong","year":"2015","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtm.2020.07.003_bib58","doi-asserted-by":"crossref","first-page":"5785","DOI":"10.1073\/pnas.1821000116","article-title":"AAV cis-regulatory sequences are correlated with ocular toxicity","volume":"116","author":"Xiong","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2020.07.003_bib59","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/sj.gt.3303074","article-title":"Assessment of ocular transduction using single-stranded and self-complementary recombinant adeno-associated virus serotype 2\/8","volume":"15","author":"Natkunarajah","year":"2008","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2020.07.003_bib60","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.exer.2010.01.011","article-title":"Self-complementary AAV5 vector facilitates quicker transgene expression in photoreceptor and retinal pigment epithelial cells of normal mouse","volume":"90","author":"Kong","year":"2010","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.omtm.2020.07.003_bib61","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1167\/iovs.06-1306","article-title":"Ocular gene transfer with self-complementary AAV vectors","volume":"48","author":"Yokoi","year":"2007","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omtm.2020.07.003_bib62","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1089\/hum.2009.218","article-title":"Replacement gene therapy with a human RPGRIP1 sequence slows photoreceptor degeneration in a murine model of Leber congenital amaurosis","volume":"21","author":"Pawlyk","year":"2010","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2020.07.003_bib63","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1126\/science.1098014","article-title":"Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration","volume":"305","author":"Araki","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.omtm.2020.07.003_bib64","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1146\/annurev-neuro-060909-153248","article-title":"Wallerian degeneration, WldS, and nmnat","volume":"33","author":"Coleman","year":"2010","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.omtm.2020.07.003_bib65","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1038\/s41467-018-03421-7","article-title":"Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults","volume":"9","author":"Martens","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtm.2020.07.003_bib66","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.cmet.2018.02.011","article-title":"Therapeutic potential of NAD-boosting molecules: the in\u00a0vivo evidence","volume":"27","author":"Rajman","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.omtm.2020.07.003_bib67","doi-asserted-by":"crossref","first-page":"9295","DOI":"10.1074\/jbc.RA118.005772","article-title":"Dihydronicotinamide riboside is a potent NAD+ concentration enhancer in\u00a0vitro and in\u00a0vivo","volume":"294","author":"Yang","year":"2019","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtm.2020.07.003_bib68","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0378-1119(91)90434-D","article-title":"Efficient selection for high-expression transfectants with a novel eukaryotic vector","volume":"108","author":"Niwa","year":"1991","journal-title":"Gene"},{"key":"10.1016\/j.omtm.2020.07.003_bib69","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/gt.2009.3","article-title":"Validation of a mutated PRE sequence allowing high and sustained transgene expression while abrogating WHV-X protein synthesis: application to the gene therapy of WAS","volume":"16","author":"Zanta-Boussif","year":"2009","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2020.07.003_bib70","first-page":"3071","article-title":"The implications of rod-dependent cone survival for basic and clinical research","volume":"40","author":"Hicks","year":"1999","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omtm.2020.07.003_bib71","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.preteyeres.2017.08.004","article-title":"The mechanism of cone cell death in retinitis pigmentosa","volume":"62","author":"Campochiaro","year":"2018","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.omtm.2020.07.003_bib72","first-page":"227","article-title":"Childhood blindness in the context of VISION 2020\u2014the right to sight","volume":"79","author":"Gilbert","year":"2001","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.omtm.2020.07.003_bib73","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1136\/bmj.327.7418.760","article-title":"Blindness in children","volume":"327","author":"Gilbert","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.omtm.2020.07.003_bib74","first-page":"175","article-title":"Susceptibility of rats to corneal lesions after injectable anesthesia","volume":"55","author":"Turner","year":"2005","journal-title":"Comp. Med."},{"key":"10.1016\/j.omtm.2020.07.003_bib75","doi-asserted-by":"crossref","first-page":"e0132804","DOI":"10.1371\/journal.pone.0132804","article-title":"Ketamine\/xylazine-induced corneal damage in mice","volume":"10","author":"Koehn","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtm.2020.07.003_bib76","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/0031-9384(86)90058-2","article-title":"Use of hypothermia for general anesthesia in preweanling rodents","volume":"38","author":"Phifer","year":"1986","journal-title":"Physiol. Behav."}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050120301522?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050120301522?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:23:23Z","timestamp":1762421003000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050120301522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":76,"alternative-id":["S2329050120301522"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2020.07.003","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gene Therapy Preserves Retinal Structure and Function in a Mouse Model of NMNAT1-Associated Retinal Degeneration","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2020.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s).","name":"copyright","label":"Copyright"}]}}